Snyder CL - Search Results

1

Family information service participation increases the rates of mutation testing among members of families with BRCA1/2 mutations.

Lynch HT, Snyder CL, Lynch JF, Ghate S, Narod SA, Gong G. Lynch HT, et al. Among authors: snyder cl. Breast J. 2009 Sep-Oct;15 Suppl 1(Suppl 1):S20-4. doi: 10.1111/j.1524-4741.2009.00807.x. Breast J. 2009. PMID: 19775326 Free PMC article.

2

Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.

Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Lynch HT, et al. Cancer Genet Cytogenet. 2006 Mar;165(2):91-7. doi: 10.1016/j.cancergencyto.2005.07.011. Cancer Genet Cytogenet. 2006. PMID: 16527602

3

Hereditary breast cancer: part II. Management of hereditary breast cancer: implications of molecular genetics and pathology.

Silva E, Gatalica Z, Snyder C, Vranic S, Lynch JF, Lynch HT. Silva E, et al. Breast J. 2008 Jan-Feb;14(1):14-24. doi: 10.1111/j.1524-4741.2007.00516.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086271

4

Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.

Lynch HT, Silva E, Snyder C, Lynch JF. Lynch HT, et al. Breast J. 2008 Jan-Feb;14(1):3-13. doi: 10.1111/j.1524-4741.2007.00515.x. Epub 2007 Dec 11. Breast J. 2008. PMID: 18086272 Review.

5

Hereditary breast cancer: practical pursuit for clinical translation.

Lynch HT, Snyder C, Lynch J. Lynch HT, et al. Ann Surg Oncol. 2012 Jun;19(6):1723-31. doi: 10.1245/s10434-012-2256-z. Epub 2012 Mar 21. Ann Surg Oncol. 2012. PMID: 22434244 Review.

6

Can unknown predisposition in familial breast cancer be family-specific?

Lynch H, Wen H, Kim YC, Snyder C, Kinarsky Y, Chen PX, Xiao F, Goldgar D, Cowan KH, Wang SM. Lynch H, et al. Breast J. 2013 Sep-Oct;19(5):520-8. doi: 10.1111/tbj.12145. Epub 2013 Jun 26. Breast J. 2013. PMID: 23800003

7

Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.

Downs B, Kim YC, Xiao F, Snyder C, Chen P, Fleissner EA, Becirovic D, Wen H, Sherman S, Cowan KH, Lynch HT, Wang SM. Downs B, et al. Breast Cancer Res Treat. 2015 May;151(1):219-24. doi: 10.1007/s10549-015-3358-7. Epub 2015 Apr 2. Breast Cancer Res Treat. 2015. PMID: 25833210

8

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.

Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Metcalfe K, et al. JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658. JAMA Oncol. 2015. PMID: 26181175

9

Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Lammert J, Lubinski J, Gronwald J, Huzarski T, Armel S, Eisen A, Meschino WS, Lynch HT, Snyder C, Eng C, Olopade OI, Ginsburg O, Foulkes WD, Elser C, Cohen SA, Kiechle M, Narod SA, Kotsopoulos J. Lammert J, et al. Breast Cancer Res Treat. 2018 Jun;169(3):561-571. doi: 10.1007/s10549-018-4694-1. Epub 2018 Feb 5. Breast Cancer Res Treat. 2018. PMID: 29404807

10

Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.

Watson P, Narod SA, Fodde R, Wagner A, Lynch JF, Tinley ST, Snyder CL, Coronel SA, Riley B, Kinarsky Y, Lynch HT. Watson P, et al. Among authors: snyder cl. J Med Genet. 2003 Aug;40(8):591-6. doi: 10.1136/jmg.40.8.591. J Med Genet. 2003. PMID: 12920070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page